COMPANY
Elucid
Elucid develops AI tools to see invisible features of risk and guide personalized, precise treatment based on a detailed analysis of patients' atherosclerotic disease. From company website Source · checked 2026-10-19
Sources for this description (1)
- Elucid develops AI tools to see invisible features of risk and guide personalized, precise treatment based on a detailed analysis of patients' atherosclerotic disease.
- “We develop AI tools to see invisible features of risk and guide personalized, precise treatment based on a detailed analysis of patients' atherosclerotic disease.” https://elucid.com/about-elucid/ (2026-10-19)
NIH awards 5
- NIH award 5R44HL126224-05 FY2021: $984,177 awarded for that fiscal year; activity R44 (SBIR); PI BUCKLER, ANDREW JOHN; recipient as written: ELUCID, BOSTON, MA. Plaque Risk Stratification Using Routinely Available CC source ↗
- NIH award 5R44HL126224-04 FY2020: $1,011,405 awarded for that fiscal year; activity R44 (SBIR); PI BUCKLER, ANDREW JOHN; recipient as written: ELUCID, BOSTON, MA. Plaque Risk Stratification Using Routinely Available source ↗
- NIH award 2R44HL126224-03A1 FY2019: $991,516 awarded for that fiscal year; activity R44 (SBIR); PI BUCKLER, ANDREW JOHN; recipient as written: ELUCID, BOSTON, MA. Plaque Risk Stratification Using Routinely Available source ↗
- NIH award 5R44HL126224-02 FY2016: $783,030 awarded for that fiscal year; activity R44 (SBIR); PI BUCKLER, ANDREW JOHN; recipient as written: ELUCID, BOSTON, MA. vascuCAP: Non-invasive Computer-Aided Phenotyping of Va source ↗
- NIH award 1R44HL126224-01A1 FY2015: $798,841 awarded for that fiscal year; activity R44 (SBIR); PI BUCKLER, ANDREW JOHN; recipient as written: ELUCID, BOSTON, MA. vascuCAP: Non-invasive Computer-Aided Phenotyping of source ↗
Open jobs 6
| Title | Location (from posting, not HQ) | Employer posted | First seen | Level |
|---|---|---|---|---|
| Director of Strategic Partnerships | Remote | Not stated | Oct 16, 2026 | Not stated |
| Area Sales Manager - Northeast, Midwest or Mid-Atlantic | Boston, MA | Not stated | Oct 11, 2026 | Mid |
| Clinical QA Specialist | Boston, MA | Not stated | Oct 11, 2026 | Entry |
| Head of Finance | Boston, MA | Not stated | Oct 11, 2026 | Executive |
| Principal Imaging and AI Engineer, Medical Imaging | Boston, MA | Not stated | Oct 11, 2026 | Senior |
| Senior Process Engineer, Clinical Operations | Boston, MA | Not stated | Oct 11, 2026 | Senior |
Connect
See your connections at Elucid on LinkedIn (search by name, results not checked)
Hiring
| Title | Location (from posting) | Employer posted | First seen |
|---|---|---|---|
| Director of Strategic Partnerships | Remote | Not stated | Oct 16, 2026 |
| Area Sales Manager - Northeast, Midwest or Mid-Atlantic | Boston, MA | Not stated | Oct 11, 2026 |
| Clinical QA Specialist | Boston, MA | Not stated | Oct 11, 2026 |
| Head of Finance | Boston, MA | Not stated | Oct 11, 2026 |
| Principal Imaging and AI Engineer, Medical Imaging | Boston, MA | Not stated | Oct 11, 2026 |